Prosecution Insights
Last updated: April 19, 2026

Dompé Farmaceutici S P A

2 pending office actions

Portfolio Summary

2
Total Pending OAs
0
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18564953 NEW THERAPEUTIC USE OF TYPE 2 IODOTHYRONINE DEIODINASE (D2) INHIBITORS CHO, DAVID H 1693 Non-Final OA Nov 28, 2023
17794935 GROWTH FACTOR FORMULATION FOR CONDITION ASSOCIATED WITH OTIC EVENT MARTINEZ, TARA L 1654 Non-Final OA Jul 22, 2022

Managing Dompé Farmaceutici S P A's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month